Cargando…
CD80 Expressed by CD8(+) T Cells Contributes to PD-L1-Induced Apoptosis of Activated CD8(+) T Cells
Tumor cells are capable of limiting antitumor CD8(+) T cell responses through their cell surface expression of PD-L1. In addition to PD-1 expressed by CD8(+) T cells, PD-L1 also binds to CD80 expressed by CD8(+) T cells. The influence of the PD-L1/CD80 interaction on CD8(+) T cell function has not b...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664331/ https://www.ncbi.nlm.nih.gov/pubmed/29181416 http://dx.doi.org/10.1155/2017/7659462 |
Sumario: | Tumor cells are capable of limiting antitumor CD8(+) T cell responses through their cell surface expression of PD-L1. In addition to PD-1 expressed by CD8(+) T cells, PD-L1 also binds to CD80 expressed by CD8(+) T cells. The influence of the PD-L1/CD80 interaction on CD8(+) T cell function has not been fully characterized, so we sought to investigate the impact of the PD-L1/CD80 interaction on PD-L1-induced apoptosis of activated CD8(+) T cells. We found that CD8(+) T cells that lacked CD80 expression got activated to the same extent as wild-type CD8(+) T cells, but when cultured with anti-CD3 and PD-L1/Fc protein, activated CD8(+) T cells that lacked CD80 expression survived better than activated wild-type CD8(+) T cells. These findings indicate that PD-L1 induces apoptosis in activated CD8(+) T cells in part by signaling through CD80. Thus, in the design and implementation of checkpoint blockade therapies that target PD-L1, it is essential that both binding partners for PD-L1, PD-1, and CD80 are considered. |
---|